Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic Clonic Seizures



Status:Enrolling by invitation
Conditions:Neurology, Neurology, Epilepsy
Therapuetic Areas:Neurology, Other
Healthy:No
Age Range:4 - Any
Updated:3/7/2019
Start Date:August 2015
End Date:March 2024

Use our guide to learn which trials are right for you!

An Open-label, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Lacosamide as Adjunctive Therapy for Uncontrolled Primary Generalized Tonic Clonic Seizures in Subjects With Idiopathic Generalized Epilepsy

Assessment of long-term safety and efficacy of oral lacosamide (LCM) as an adjunctive therapy
for uncontrolled primary generalized tonic-clonic (PGTC) seizures in subjects >= 4 years of
age with idiopathic generalized epilepsy (IGE). This study will enroll subjects from the LCM
SP0982 (NCT02408523) study.


Inclusion Criteria:

-Subject must have completed or be an eligible Baseline failure from the parent study
(SP0982). Note: Other subjects screened for SP0982 may be considered for roll-over to
EP0012 if the investigator considers that the subject could benefit from treatment with
open-label lacosamide (LCM) and based on prior discussion with and approval from the UCB
Study Physician or representative.

Exclusion Criteria:

- Subject is receiving any investigational drugs or using any experimental devices in
addition to Lacosamide (LCM)

- Subject meets the withdrawal criteria for SP0982 or is experiencing an ongoing serious
adverse event (SAE)

- Subject has an active suicidal ideation as indicated by a positive response ("Yes") to
either Question 4 or Question 5 of the "Since Last Visit" version of the
Columbia-Suicide Severity Rating Scale (C-SSRS)

- Subject has >=2x upper limit of normal (ULN) of any of the following: alanine
aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP),
or >ULN total bilirubin (≥1.5xULN total bilirubin if known Gilbert's syndrome). If
subject has elevations only in total bilirubin that are >ULN and <1.5xULN, fractionate
bilirubin to identify possible undiagnosed Gilbert's syndrome (ie, direct bilirubin
<35%).

For randomized subjects with a Baseline result >ULN for ALT, AST, ALP, or total bilirubin,
a Baseline diagnosis and/or the cause of any clinically meaningful elevation must be
understood and recorded in the Case Report form (CRF).

If subject has >ULN ALT, AST, or ALP that does not meet the exclusion limit at screening,
repeat the tests, if possible, prior to dosing to ensure there is no further ongoing
clinically relevant increase. In case of a clinically relevant increase, inclusion of the
subject must be discussed with the Medical Monitor. Tests that result in ALT, AST, or ALP
up to 25% above the exclusion limit may be repeated once for confirmation. This includes
re-screening.
We found this trial at
28
sites
Little Rock, Arkansas
?
mi
from
Little Rock, AR
Click here to add this to my saved trials
Austin, Texas
?
mi
from
Austin, TX
Click here to add this to my saved trials
Boise, Idaho
?
mi
from
Boise, ID
Click here to add this to my saved trials
Chatswood,
?
mi
from
Chatswood,
Click here to add this to my saved trials
Chicago, Illinois
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Colorado Springs, Colorado
?
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Danbury, Connecticut
?
mi
from
Danbury, CT
Click here to add this to my saved trials
Golden Valley, Minnesota
?
mi
from
Golden Valley, MN
Click here to add this to my saved trials
Greenville, Texas
?
mi
from
Greenville, TX
Click here to add this to my saved trials
Houston, Texas
?
mi
from
Houston, TX
Click here to add this to my saved trials
Irvine, California
?
mi
from
Irvine, CA
Click here to add this to my saved trials
Loxahatchee Groves, Florida
?
mi
from
Loxahatchee Groves, FL
Click here to add this to my saved trials
Madison, Wisconsin
?
mi
from
Madison, WI
Click here to add this to my saved trials
New Orleans, Louisiana
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
New York, New York
?
mi
from
New York, NY
Click here to add this to my saved trials
Omaha, Nebraska
?
mi
from
Omaha, NE
Click here to add this to my saved trials
Panama City, Florida
?
mi
from
Panama City, FL
Click here to add this to my saved trials
Peoria, Illinois
?
mi
from
Peoria, IL
Click here to add this to my saved trials
Philadelphia, Pennsylvania
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Port Charlotte, Florida
?
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Renton, Washington
?
mi
from
Renton, WA
Click here to add this to my saved trials
Saint Louis, Missouri
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
San Antonio, Texas
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
San Antonio, Texas
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
Santa Monica, California
?
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Savannah, Georgia
?
mi
from
Savannah, GA
Click here to add this to my saved trials
Tampa, Florida
?
mi
from
Tampa, FL
Click here to add this to my saved trials
Winchester, Virginia
?
mi
from
Winchester, VA
Click here to add this to my saved trials